These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19275537)

  • 1. High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery.
    Wan H; Holmén AG
    Comb Chem High Throughput Screen; 2009 Mar; 12(3):315-29. PubMed ID: 19275537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Wan H; Ahman M; Holmén AG
    J Med Chem; 2009 Mar; 52(6):1693-700. PubMed ID: 19256501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a rapid and integrated analysis system (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography/tandem mass spectrometry.
    Luippold AH; Arnhold T; Jörg W; Krüger B; Süssmuth RD
    J Biomol Screen; 2011 Mar; 16(3):370-7. PubMed ID: 21335598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
    Shou WZ; Zhang J
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
    Roberts SA
    Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro ADME profiling using high-throughput rapidfire mass spectrometry: cytochrome p450 inhibition and metabolic stability assays.
    Wu X; Wang J; Tan L; Bui J; Gjerstad E; McMillan K; Zhang W
    J Biomol Screen; 2012 Jul; 17(6):761-72. PubMed ID: 22460176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated techniques in pK
    Dardonville C
    Drug Discov Today Technol; 2018 Jul; 27():49-58. PubMed ID: 30103863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.
    Zhang J; Shou WZ; Vath M; Kieltyka K; Maloney J; Elvebak L; Stewart J; Herbst J; Weller HN
    Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3593-601. PubMed ID: 21080511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipophilicity and biomimetic properties to support drug discovery.
    Tsopelas F; Giaginis C; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2017 Sep; 12(9):885-896. PubMed ID: 28644732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput pKa screening and prediction amenable for ADME profiling.
    Wan H; Ulander J
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):139-55. PubMed ID: 16863474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of mass spectrometry for in-vitro ADME assays.
    Chu I; Nomeir AA
    Curr Drug Metab; 2006 Jun; 7(5):467-77. PubMed ID: 16787156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High throughput screening of pharmacokinetics and metabolism in drug discovery (I)--establishment of assessment system for absorption to compounds with a wide diversity of physical properties].
    Komura H; Kawahara I; Shigemoto Y; Matsuda K; Ano R; Murayama Y; Moriwaki T; Yoshida NH
    Yakugaku Zasshi; 2005 Jan; 125(1):121-30. PubMed ID: 15635283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery.
    Korfmacher WA; Cox KA; Ng KJ; Veals J; Hsieh Y; Wainhaus S; Broske L; Prelusky D; Nomeir A; White RE
    Rapid Commun Mass Spectrom; 2001; 15(5):335-40. PubMed ID: 11241763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery.
    Ackermann BL; Berna MJ; Murphy AT
    Curr Top Med Chem; 2002 Jan; 2(1):53-66. PubMed ID: 11899065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries.
    Jenkins KM; Angeles R; Quintos MT; Xu R; Kassel DB; Rourick RA
    J Pharm Biomed Anal; 2004 Mar; 34(5):989-1004. PubMed ID: 15019033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of "hit-to-lead" optimization by integration of in vitro HTS experimental models for early determination of pharmacokinetic properties.
    Kariv I; Rourick RA; Kassel DB; Chung TD
    Comb Chem High Throughput Screen; 2002 Sep; 5(6):459-72. PubMed ID: 12470275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery.
    Smith NF; Raynaud FI; Workman P
    Mol Cancer Ther; 2007 Feb; 6(2):428-40. PubMed ID: 17308044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct plasma sample injection in multiple-component LC-MS-MS assays for high-throughput pharmacokinetic screening.
    Wu JT; Zeng H; Qian M; Brogdon BL; Unger SE
    Anal Chem; 2000 Jan; 72(1):61-7. PubMed ID: 10655635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution.
    Henchoz Y; Bard B; Guillarme D; Carrupt PA; Veuthey JL; Martel S
    Anal Bioanal Chem; 2009 Jun; 394(3):707-29. PubMed ID: 19184676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.